Varex Imaging CORP (VREX) — SEC Filings

Q: What are the key financial highlights for Varex Imaging CORP?

Key financial highlights for Varex Imaging CORP are extracted from the most recent 10-K or 10-Q filings, including revenue, net income, EPS, debt-to-equity, cash position, and operating margin.

Q: Who are the key executives at Varex Imaging CORP?

Key executives at Varex Imaging CORP are identified from SEC filings including 10-K annual reports, proxy statements, and insider trade forms.

Q: What are the main risk factors for Varex Imaging CORP stock?

Risk factors for Varex Imaging CORP (VREX) are assessed from SEC filings using AI analysis. Each filing is categorized as high, medium, or low risk based on disclosed risk factors and financial indicators.

Q: What are recent predictions and forward guidance from Varex Imaging CORP?

Forward-looking statements and predictions from Varex Imaging CORP are extracted from SEC filings including earnings reports, annual reports, and current event filings.

Latest SEC filings for Varex Imaging CORP. Recent DEF 14A filing on Dec 29, 2025. AI-decoded analysis of earnings, risk factors, and insider trades.

View Varex Imaging CORP on SEC EDGAR

Overview

Varex Imaging CORP (VREX) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a DEF 14A filed on Dec 29, 2025: Varex Imaging Corporation's DEF 14A filing outlines the agenda for its 2026 Annual Meeting of Stockholders on February 12, 2026, which will be a virtual meeting. Key proposals include the election of seven directors, an advisory vote on named executive officer compensation, and the ratification of D

Sentiment Summary

Across 32 filings, the sentiment breakdown is: 1 bullish, 1 bearish, 29 neutral, 1 mixed. The dominant filing sentiment for Varex Imaging CORP is neutral.

Filing Type Overview

Varex Imaging CORP (VREX) has filed 2 DEF 14A, 2 10-K, 8 8-K, 6 10-Q, 1 8-K/A, 1 DEFA14A, 9 SC 13G/A, 3 SC 13G with the SEC between Jan 2024 to Dec 2025.

Filings by Year

2025 · 2024

Recent Filings (32)

Varex Sets Virtual 2026 Annual Meeting, Board Recommends All Proposals — DEF 14A · Dec 29, 2025 Risk: low
Varex Imaging Corporation's DEF 14A filing outlines the agenda for its 2026 Annual Meeting of Stockholders on February 12, 2026, which will be a virtual meeting
Varex Imaging's Top 5 Customers Drive 40% of 2025 Revenue — 10-K · Nov 18, 2025 Risk: medium
Varex Imaging Corporation (VREX) reported that its top five customers, including Canon Medical Systems Corporation, United Imaging Healthcare, General Electric
Varex Imaging Corp. Announces Board and Executive Changes — 8-K · Sep 11, 2025 Risk: medium
Varex Imaging Corporation announced on September 5, 2025, a change in its board of directors and executive compensation arrangements. The filing details the dep
Varex Swings to Q3 Loss Amid Revenue Dip — 10-Q · Aug 7, 2025 Risk: high
Varex Imaging Corp (VREX) reported a net loss of $1.5 million for the third quarter ended July 4, 2025, a significant decline from the net income of $10.1 milli
Varex Imaging Corp. Files 10-Q for Period Ending April 4, 2025 — 10-Q · May 8, 2025 Risk: medium
Varex Imaging Corp. reported its financial results for the period ending April 4, 2025. The company's filing indicates a fiscal year end of October 3rd. Key fin
Varex Imaging Corp. Files 8-K for Regulation FD Disclosure — 8-K · Apr 4, 2025 Risk: low
Varex Imaging Corp. filed an 8-K on April 4, 2025, to report a Regulation FD Disclosure. The filing does not contain specific details about the nature of the di
Varex Imaging Files 8-K with Corporate Updates — 8-K · Feb 14, 2025 Risk: low
Varex Imaging Corporation filed an 8-K on February 14, 2025, reporting events as of February 13, 2025. The filing indicates changes to the company's Articles of
Varex Imaging Corp. Files 10-Q for Period Ending Jan 3, 2025 — 10-Q · Feb 6, 2025 Risk: medium
Varex Imaging Corp. filed its 10-Q for the period ending January 3, 2025. The filing details the company's financial position and operational performance. Key f
Varex Imaging Corp Files Amendment on Material Agreement Termination — 8-K/A · Jan 6, 2025 Risk: medium
Varex Imaging Corporation filed an amendment (8-K/A) on January 6, 2025, regarding an event that occurred on December 20, 2024. The filing pertains to the termi
Varex Imaging Files Proxy Statement Amendment — DEFA14A · Jan 2, 2025 Risk: low
Varex Imaging Corp. filed an amendment (DEFA14A) to its proxy statement on January 2, 2025, concerning its annual meeting. The filing indicates no fee was requi
Varex Imaging Files Definitive Proxy Statement — DEF 14A · Dec 30, 2024 Risk: low
Varex Imaging Corp. filed its definitive proxy statement (DEF 14A) on December 30, 2024, for its fiscal year ending September 27, 2025. The filing, related to t
Varex Imaging Corp Files 8-K: Agreements and Obligations — 8-K · Dec 23, 2024 Risk: medium
On December 20, 2024, Varex Imaging Corporation entered into a Material Definitive Agreement and also terminated a Material Definitive Agreement. The company al
Varex Imaging Corp Files 8-K: Material Definitive Agreement — 8-K · Dec 17, 2024 Risk: medium
On December 13, 2024, Varex Imaging Corporation entered into a Material Definitive Agreement. The filing also includes information on other events and financial
Varex Imaging Corp. Files 2024 Annual Report — 10-K · Nov 19, 2024 Risk: medium
Varex Imaging Corp. filed its 10-K for the fiscal year ending September 27, 2024. The company, headquartered in Salt Lake City, UT, operates in the electronic c
SC 13G/A Filing — SC 13G/A · Nov 12, 2024
SC 13G/A Filing — SC 13G/A · Nov 4, 2024
SC 13G/A Filing — SC 13G/A · Oct 9, 2024
SC 13G/A Filing — SC 13G/A · Oct 7, 2024
Varex Imaging Corp Files 8-K — 8-K · Sep 11, 2024 Risk: low
On September 11, 2024, Varex Imaging Corporation filed an 8-K report. The filing primarily concerns "Other Events" and does not detail specific transactions or
Varex Imaging Corp Files 10-Q for Q3 2024 — 10-Q · Aug 1, 2024 Risk: medium
Varex Imaging Corp filed its 10-Q for the period ending June 28, 2024. The filing details the company's financial performance and position. Key financial data a
Varex Imaging Corp Files 10-Q for Period Ending March 29, 2024 — 10-Q · May 2, 2024 Risk: low
Varex Imaging Corp (VREX) filed a Quarterly Report (10-Q) with the SEC on May 2, 2024. Varex Imaging Corp filed a 10-Q report for the period ending March 29, 20
Varex Imaging Corp Files 8-K on Agreements and Obligations — 8-K · Mar 27, 2024 Risk: medium
On March 26, 2024, Varex Imaging Corporation entered into a Material Definitive Agreement and also terminated a Material Definitive Agreement. The company also
SC 13G Filing — SC 13G · Feb 14, 2024
SC 13G/A Filing — SC 13G/A · Feb 13, 2024
SC 13G Filing — SC 13G · Feb 13, 2024
Janus Henderson Amends Varex Imaging Stake, Reports 462 Shared Votes — SC 13G/A · Feb 12, 2024 Risk: low
Janus Henderson Group plc, a major investment firm, filed an amended SC 13G/A on February 12, 2024, disclosing its ownership in Varex Imaging Corporation. As of
Varex Imaging Files 8-K on Security Holder Vote Matters — 8-K · Feb 9, 2024 Risk: low
Varex Imaging Corporation filed an 8-K on February 9, 2024, reporting an event that occurred on February 8, 2024. This filing is a routine submission of matters
Dimensional Fund Advisors Reports 2.47M Share Stake in Varex Imaging — SC 13G · Feb 9, 2024 Risk: low
Dimensional Fund Advisors LP, a Delaware Limited Partnership, reported beneficial ownership of 2,470,148 shares of Varex Imaging Corp (VREX) Common Stock as of
Varex Imaging Corp Files 10-Q for Period Ending December 29, 2023 — 10-Q · Feb 6, 2024 Risk: medium
Varex Imaging Corp (VREX) filed a Quarterly Report (10-Q) with the SEC on February 6, 2024. Varex Imaging Corp filed a 10-Q report for the period ending Decembe
State Street Corp Updates Passive Stake in Varex Imaging — SC 13G/A · Jan 23, 2024
State Street Corporation, a major financial institution, filed an amended SC 13G/A on January 23, 2024, indicating its ownership of Varex Imaging Corp's common
BlackRock Maintains 5.0% Passive Stake in Varex Imaging — SC 13G/A · Jan 19, 2024
BlackRock Inc. filed an amended SC 13G/A on January 19, 2024, disclosing its ownership of Varex Imaging Corporation's Common Stock as of December 31, 2023. This
Allspring Global Investments Holds 7.6% Stake in Varex Imaging — SC 13G/A · Jan 12, 2024
Allspring Global Investments Holdings, LLC, a major investment firm, filed an amended SC 13G/A on January 12, 2024, disclosing its ownership in Varex Imaging Co

Risk Profile

Risk Assessment: Of VREX's 22 recent filings, 1 were flagged as high-risk, 11 as medium-risk, and 10 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.

Financial Highlights

Key financial metrics from Varex Imaging CORP's most recent 10-K filing (Nov 18, 2025):

Revenue: N/A
Net Income: N/A
EPS: N/A
Debt-to-Equity: N/A
Cash Position: N/A
Operating Margin: N/A
Total Assets: N/A
Total Debt: N/A

Key Executives

Walter M Rosebrough, Jr.
Matthew A. Martinez
Kathleen L. Bardwell
Sunny S. Sanyal
Christine A. Tsingos

Industry Context

Varex Imaging Corporation operates in the X-ray imaging components and systems market, serving both medical and industrial applications. The industry is characterized by technological innovation in areas like digital detectors and image processing, driven by demand for higher resolution, faster imaging, and more portable solutions. Competition often centers on product performance, reliability, and integration capabilities within larger imaging systems.

Top Tags

amendment (6) · 10-Q (5) · institutional-ownership (5) · financials (4) · SEC Filing (3) · sec-filing (3) · passive-investment (3) · Medical Imaging (2) · Healthcare Technology (2) · reporting (2)

Executive Compensation

From the most recent DEF 14A filing (Dec 29, 2025):

Not Disclosed — Not Disclosed: $0

Key Numbers

Number of directors to be elected: 7 — Serving until the 2027 Annual Meeting of Stockholders
Fiscal year for auditor ratification: 2026 — Deloitte & Touche LLP appointed for fiscal year 2026
Record date for voting eligibility: 2025-12-15 — Stockholders of record on this date can vote at the 2026 Annual Meeting
Shares of common stock outstanding: 41,919,432 — As of the record date, December 15, 2025
Average director tenure: 7.5 years — As of December 15, 2025, indicating board stability
Maximum fee for proxy solicitation: $11,000 — Paid to Georgeson LLC, plus reasonable out-of-pocket expenses
Date of 2026 Annual Meeting of Stockholders: 2026-02-12 — Meeting will be held virtually at 4:30 p.m. Mountain Time
Deadline for 2027 stockholder proposals (Rule 14a-8): 2026-09-01 — Proposals must be received by this date for inclusion in the 2027 proxy statement
Deadline for 2027 stockholder proposals (outside Rule 14a-8): 2026-11-14 — Proposals must be delivered no later than this date
Proxy submission deadline: 11:59 p.m. Eastern Time on February 11, 2026 — For telephone and Internet voting by stockholders of record
aggregate market value of non-affiliate common stock: $339.3 million — as of April 4, 2025
shares of common stock outstanding: 41.7 million — as of November 11, 2025
revenue from top five customers: 40% — in fiscal year 2025
revenue from Canon Medical Systems Corporation: 18% — in fiscal year 2025
revenue from top ten customers: 52% — in fiscal year 2025

Forward-Looking Statements

{"claim":"Janus Henderson Group plc will maintain its current, albeit small, shared voting power in Varex Imaging Corp. for the foreseeable future.","entity":"Janus Henderson Group plc","targetDate":"Q2 2024","confidence":"medium"}
{"claim":"Varex Imaging Corp stock may experience increased stability due to significant institutional ownership.","entity":"Varex Imaging Corp","targetDate":"Next 6-12 months","confidence":"medium"}

Frequently Asked Questions

What are the latest SEC filings for Varex Imaging CORP (VREX)?

Varex Imaging CORP has 32 recent SEC filings from Jan 2024 to Dec 2025, including 9 SC 13G/A, 8 8-K, 6 10-Q. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of VREX filings?

Across 32 filings, the sentiment breakdown is: 1 bullish, 1 bearish, 29 neutral, 1 mixed. The dominant sentiment is neutral.

Where can I find Varex Imaging CORP SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Varex Imaging CORP (VREX) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Varex Imaging CORP?

Key financial highlights from Varex Imaging CORP's most recent 10-K include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.

What is the investment thesis for VREX?

The investment thesis for VREX includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Varex Imaging CORP?

Key executives identified across Varex Imaging CORP's filings include Walter M Rosebrough, Jr., Matthew A. Martinez, Kathleen L. Bardwell, Sunny S. Sanyal, Christine A. Tsingos.

What are the main risk factors for Varex Imaging CORP stock?

Of VREX's 22 assessed filings, 1 were flagged high-risk, 11 medium-risk, and 10 low-risk.

What are recent predictions and forward guidance from Varex Imaging CORP?

Recent forward-looking statements from Varex Imaging CORP include guidance on {"claim":"Janus Henderson Group plc will maintain its current, albeit small, shared voting power in Varex Imaging Corp. and 1 other predictions.